Inhibitory activity of Ferroquine, versus Chloroquine, against western Kenya Plasmodium falciparum field isolates determined by a SYBR green I in vitro assay

American Journal of Tropical Medicine and Hygiene

Volumn 85, Issue 6, 2011, Pages 984-988

  Eyase, Fredrick L ^a   Akala, Hoseah M ^a   Johnson, Jacob D ^a   Walsh, Douglas S ^b  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; FERROQUINE;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GENE MUTATION; HUMAN; IC 50; IN VITRO STUDY; KENYA; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINOQUINOLINES; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; FERROUS COMPOUNDS; HUMANS; KENYA; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTOZOAN PROTEINS;

EID: 83255162438     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.11-0260     Document Type: Article

References (28)

1. Leimanis ML, Jaidee A, Sriprawat K, Kaewpongsri S, Suwanarusk R, Barends M, Phyo AP, Russell B, Renia L, Nosten F, 2010. Plasmodium vivax susceptibility to ferroquine. Antimicrob Agents Chemother 54: 2228-2230.
2. Atteke C, Ndong JM, Aubouy A, Maciejewski L, Brocard J, Lebibi J, Deloron P, 2003 . In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooue region of Gabon. J Antimicrob Chemother 51: 1021-1024. (Pubitemid 36503439)
3. Barends M, Jaidee A, Khaohirun N, Singhasivanon P, Nosten F, 2007. In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border. Malar J 6: 81.
4. Biot C, Taramelli D, Forfar-Bares I, Maciejewski LA, Boyce M, Nowogrocki G, Brocard JS, Basilico N, Olliaro P, Egan TJ, 2005. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity. Mol Pharm 2: 185-193. (Pubitemid 40921742)
5. Daher W, Biot C, Fandeur T, Jouin H, Pelinski L, Viscogliosi E, Fraisse L, Pradines B, Brocard J, Khalife J, Dive D, 2006. Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure. Malar J 5: 11.
6. Dubar F, Khalife J, Brocard J, Dive D, Biot C, 2008. Ferroquine, an ingenious antimalarial drug: thoughts on the mechanism of action. Molecules 13: 2900-2907.
7. Henry M, Briolant S, Fontaine A, Mosnier J, Baret E, Amalvict R, Fusai T, Fraisse L, Rogier C, Pradines B, 2008. In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum. Antimicrob Agents Chemother 52: 2755-2759.
8. Kreidenweiss A, Kremsner PG, Dietz K, Mordmuller B, 2006. In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum. Am J Trop Med Hyg 75: 1178-1181. (Pubitemid 351627504)
9. Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Doumbo OK, 1997. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 176: 1590-1596. (Pubitemid 27518161)
10. Mbaisi A, Liyala P, Eyase F, Achilla R, Akala H, Wangui J, Mwangi J, Osuna F, Alam U, Smoak BL, Davis JM, Kyle DE, Coldren RL, Mason C, Waters NC, 2004. Drug susceptibility and genetic evaluation of Plasmodium falciparum isolates obtained in four distinct geographical regions of Kenya. Antimicrob Agents Chemother 48: 3598-3601. (Pubitemid 39129371)
11. Mwai L, Ochong E, Abdirahman A, Kiara SM, Ward S, Kokwaro G, Sasi P, Marsh K, Borrmann S, Mackinnon M, Nzila A, 2009. Chloroquine resistance before and after its withdrawal in Kenya. Malar J 8: 106.
12. Malakooti MA, Biomndo K, Shanks GD, 1998. Reemergence of epidemic malaria in the highlands of western Kenya. Emerg Infect Dis 4: 671-676. (Pubitemid 28553696)
13. Bacon DJ, Latour C, Lucas C, Colina O, Ringwald P, Picot S, 2007. Comparison of a SYBR green I-based assay with a histidinerich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates. Antimicrob Agents Chemother 51: 1172-1178. (Pubitemid 46586790)
14. Johnson JD, Dennull RA, Gerena L, Lopez-Sanchez M, Roncal NE, Waters NC, 2007. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother 51: 1926-1933. (Pubitemid 46903075)
15. Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M, 2004 . Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 48: 1803-1806. (Pubitemid 38544392)
16. Akala HM, Eyase FL, Cheruiyot AR, Omondi AA, Ogutu BR, Waters NC, Johnson JD, Polhemus ME, Schnabel DC, Walsh DS, 2011. Anti-malarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay, and molecular analysis. Am J Trop Med Hyg 85: 34-41.
17. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD, 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16: 710-718. (Pubitemid 10082023)
18. Ferreira ID, Rosario VE, Cravo PV, 2006. Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum. Malar J 5: 1.
19. Nelson AL, Purfield A, McDaniel P, Uthaimongkol N, Buathong N, Sriwichai S, Miller RS, Wongsrichanalai C, Meshnick SR, 2005. pfmdr1 genotyping and in vivo mefloquine resistance on the Thai-Myanmar border. Am J Trop Med Hyg 72: 586-592. (Pubitemid 41278828)
20. Purfield A, Nelson A, Laoboonchai A, Congpuong K, McDaniel P, Miller RS, Welch K, Wongsrichanalai C, Meshnick SR, 2004. A new method for detection of pfmdr1 mutations in Plasmodium falciparum DNA using real-time PCR. Malar J 3: 9.
21. Blackie MA, Chibale K, Beagley P, Croft SL, Kendrick H, Moss JR, 2008. Metallocene antimalarials: the continuing quest Metallocene-based antimalarials: an exploration into the influence of the ferrocenyl moiety on in vitro antimalarial activity in chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum. Met Based Drugs 2008: 495123.
22. Delhaes L, Abessolo H, Biot C, Berry L, Delcourt P, Maciejewski L, Brocard J, Camus D, Dive D, 2001. In vitro and in vivo antimalarial activity of ferrochloroquine, a ferrocenyl analogue of chloroquine against chloroquine-resistant malaria parasites. Parasitol Res 87: 239-244. (Pubitemid 32208941)
23. Delhaes L, Biot C, Berry L, Delcourt P, Maciejewski LA, Camus D, Brocard JS, Dive D, 2002. Synthesis of ferroquine enantiomers: first investigation of effects of metallocenic chirality upon antimalarial activity and cytotoxicity. ChemBioChem 3: 418-423. (Pubitemid 36002285)
24. Mookherjee S, Howard V, Nzila-Mouanda A, Watkins W, Sibley CH, 1999. Identification and analysis of dihydrofolate reductase alleles from Plasmodium falciparum present at low frequency in polyclonal patient samples. Am J Trop Med Hyg 61: 131-140. (Pubitemid 29345002)
25. Domarle O, Blampain G, Agnaniet H, Nzadiyabi T, Lebibi J, Brocard J, Maciejewski L, Biot C, Georges AJ, Millet P, 1998 . In vitro antimalarial activity of a new organometallic analog, ferrocene-chloroquine. Antimicrob Agents Chemother 42: 540-544. (Pubitemid 28114805)
26. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR, 2002. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2: 209-218. (Pubitemid 34464751)
27. Holmgren G, Bjorkman A, Gil JP, 2006 . Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya. Trop Med Int Health 11: 1808-1812. (Pubitemid 44813875)
28. Nkhoma S, Nair S, Mukaka M, Molyneux ME, Ward SA, Anderson TJ, 2009. Parasites bearing a single copy of the multi-drug resistance gene (pfmdr-1) with wild-type SNPs predominate amongst Plasmodium falciparum isolates from Malawi. Acta Trop 111: 78-81.